AgeX Therapeutics Company
Biotechnology company focused on regenerative medicine and cellular therapies derived from pluripotent stem cells. Founded in 2017 (a spinoff from BioTime), AgeX develops technologies for tissue replacement and rejuvenation in degenerative diseases. The company also licenses platform tools such as PureStem® (cell derivation) and UniCyte® (reprogramming). Its strategy centers on restoring youthful regenerative capacity to human tissues. (agexinc.com)
Investors
%20.jpg)
Founded Date:
2017
Estimated Revenue:
$0.142M (FY2023)
Headquarters:
1101 Marina Village Parkway, Suite 201, Alameda, CA, USA
Employee Number:
13